Specific HIV/AIDS Medication Interactions

General

ARV Alert (Regularly Updated)
Periodic updates on newly announced interactions involving HIV medications; each update features a brief synopsis of the interaction, as well as a chart outlining key information.
From HIV InSite
Patient Information About Reyataz (Atazanavir) (PDF) (January 2013)
From Bristol-Myers Squibb Company
Aspirin Dampens Immune Activation in HIV+ People on ART (August 10, 2012)
From HIVandHepatitis.com
Are You a Good Interaction, or a Bad Interaction? (March/April 2012)
A guide to HIV drug interactions.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Making Sense of the Drug Interaction Warning for HIV/HCV-Coinfected Patients Taking Victrelis: A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
Results of Pharmacokinetic Study in Healthy Volunteers Given Victrelis (Boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected With Chronic Hepatitis C and HIV (February 6, 2012)
To read PDF, click here.
From Merck & Co., Inc.
Elvitegravir/Cobicistat and Acid Reducing Agents (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Nelfinavir Interaction With Warfarin (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Intelence (Etravirine) Label Revised to Include New Drug-Drug Interaction Information (March 11, 2010)
From U.S. Food and Drug Administration

VIEW ALL ARTICLES

St. John's Wort

St. John's Wort Interferes With Chemotherapy, Study Shows (August 31, 2002)
The herb is found to dramatically decrease blood levels of a key cancer-fighting drug.
In British Medical Journal
St. John's Wort Found to Lower Nevirapine Levels (March 2, 2001)
From Canadian AIDS Treatment Information Exchange
NIH Study Cautions Use of St. John's Wort With Anti-HIV Drugs (April 2000)
In Project Inform Perspective, from Project Inform
St. John's Wort Warning: Do Not Combine With Protease Inhibitors, NNRTIs (February 18, 2000)
From AIDS Treatment News
NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort and an HIV Protease Inhibitor (February 10, 2000)
From U.S. National Institutes of Health
Treatment Briefs: St. John's Wort Lowers Indinavir (and Possibly Other) Drug Levels (Winter 1999/2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis

Viagra

The Dangers of Using and Abusing Viagra (November/December 2004)
In Survival News, from AIDS Survival Project
Viagra and Grapefruit Juice -- Not a Good Mix (February 12, 2002)
From Canadian AIDS Treatment Information Exchange
Viagra: New Warning With Protease Inhibitors (May 7, 1999)
From AIDS Treatment News
Protease Inhibitors, Sexual Dysfunction, and Viagra (March 1999)
Pfizer issues an alert.
In GMHC Treatment Issues, from Gay Men's Health Crisis

Birth Control Pills

Nevirapine-Containing ART Does Not Reduce Combined Oral Contraceptive Effectiveness (January/February 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Hormonal Contraception: HIV Transmission and Progression Rates (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
Hormonal Contraception and Higher Risk of Non-AIDS-Defining Events in Nashville Cohort (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Hormonal Contraception and HIV Transmission Risk (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
Study: HIV Risks Rise With Some Birth Control (July 26, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hormone-Based Birth Control Raises HIV Risk (July 21, 2011)
From AIDSmeds.com
Hormonal Contraceptive Use Increases Women's Risk of Acquiring and Transmitting HIV (July 21, 2011)
From aidsmap.com
Quad Reduces Levels of Oral Contraceptives (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Women and HIV: Hormonal Contraception for HIV Positive Women (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
Antiretroviral Medications and Oral Contraceptive Agents (2007)
From Clinical Manual for Management of the HIV-Infected Adult.
In Canadian Medical Association Journal, from AIDS Education & Training Centers National Resource Center
High Dose of Vitamin C Significantly Reduces Indinavir Levels in Pilot Study (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
Viramune Affects Birth Control in HIV+ Women (March 31, 2000)
In STEP Ezine, from Seattle Treatment Education Project
Pregnant Pause (Summer 1998)
Interaction between antiretrovirals and birth control pills.
In STEP Perspective, from Seattle Treatment Education Project

Vitamins

Vitamin A (Beta Carotene and Retinoids) and HIV Drug Interactions (January 2003)
Research from the 2002 International AIDS Conference.
In Project Inform Perspective, from Project Inform
Vitamin E, Vitamin A and Anti-HIV Therapies (January 2003)
Research from the 2002 International AIDS Conference.
In Project Inform Perspective, from Project Inform